Loading...
CME Group Inc.
0HR2.L•LSE
Financial ServicesFinancial - Diversified
£274.08
£-2.33(-0.84%)
CME Group Inc. (0HR2.L) Financial Performance & Statements
Review CME Group Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
9.88%
↑ 9.88%
Operating Income Growth
14.43%
↑ 14.43%
Net Income Growth
9.29%
↑ 9.29%
Operating Cash Flow Growth
6.85%
↑ 6.85%
Operating Margin
64.92%
↑ 64.92%
Gross Margin
86.46%
↑ 86.46%
Net Profit Margin
57.18%
↑ 57.18%
ROE
13.14%
↑ 13.14%
ROIC
11.21%
↑ 11.21%
CME Group Inc. (0HR2.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for CME Group Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.53B | $1.58B | $1.53B | $1.49B |
| Cost of Revenue | $220.80M | $218.80M | $204.70M | $206.00M |
| Gross Profit | $1.30B | $1.37B | $1.33B | $1.28B |
| Gross Profit Ratio | $0.86 | $0.86 | $0.87 | $0.86 |
| R&D Expenses | $0.00 | $66.60M | $64.10M | $59.40M |
| SG&A Expenses | $33.90M | $31.00M | $34.70M | $33.10M |
| Operating Expenses | $357.40M | $341.40M | $327.20M | $322.30M |
| Total Costs & Expenses | $578.20M | $560.20M | $531.90M | $528.30M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $40.70M | $40.20M | $40.10M | $39.90M |
| Depreciation & Amortization | $83.40M | $83.90M | $84.20M | $85.30M |
| EBITDA | $1.22B | $1.30B | $1.08B | $1.04B |
| EBITDA Ratio | $0.80 | $0.82 | $0.71 | $0.70 |
| Operating Income | $947.10M | $1.02B | $1.001B | $959.60M |
| Operating Income Ratio | $0.62 | $0.65 | $0.65 | $0.64 |
| Other Income/Expenses (Net) | $149.50M | $152.70M | $153.90M | $153.80M |
| Income Before Tax | $1.10B | $1.18B | $1.15B | $1.11B |
| Income Before Tax Ratio | $0.72 | $0.74 | $0.75 | $0.75 |
| Income Tax Expense | $222.00M | $264.10M | $271.30M | $258.20M |
| Net Income | $874.60M | $879.40M | $883.20M | $855.20M |
| Net Income Ratio | $0.57 | $0.56 | $0.58 | $0.57 |
| EPS | $2.46 | $2.51 | $2.43 | $2.35 |
| Diluted EPS | $2.46 | $2.50 | $2.42 | $2.35 |
| Weighted Avg Shares Outstanding | $359.57M | $359.40M | $359.33M | $359.26M |
| Weighted Avg Shares Outstanding (Diluted) | $360.05M | $359.99M | $359.87M | $359.83M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan